Performance Assessement for Paralympic Athletes

NCT ID: NCT04748497

Last Updated: 2022-03-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

134 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-01-08

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of the study: improvement of sportive performances by quantification and performances monitoring of paralympic athletes.

The secondary objectives of the study:

* quantification and performances monitoring of mechanical performances during the filed tests, the laboratory analysis and the sportive competitions;
* quantification and performances monitoring of physiological performances during the filed tests, the laboratory analysis and the sportive competitions;
* quantification and risk monitoring of discipline-relative musculo-squeletic troubles, caused by training or using of sportive equipment;
* quantification and mechanical monitoring by the made-to-measure or usual sportive material.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The sportive performance results from a range of determinations such as: physiological, biomechanical, morphological, psychological, social and environmental factors. The interactions between athletes, equipment, training and environment influences the development of athletes' performance. In the context of the coming Paris 2024 Paralympic Games, the performance construction for the exploration, the quantification and the management of all factors is an commun objective between sportive team, medical team and researchers.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Paralympic Athletes Sportive Performance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Parasportives of various disciplines

Group Type OTHER

Standardization of evaluation and follow-up

Intervention Type OTHER

Standardization of evaluation and clinical and sportive follow-up of athletes.

Made-to-measure technical supports will be tested regarding the Paralympic regulations.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standardization of evaluation and follow-up

Standardization of evaluation and clinical and sportive follow-up of athletes.

Made-to-measure technical supports will be tested regarding the Paralympic regulations.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* High-lever paralympic athletes registered on the ministerial list or selected by Parasport Federation of France or Shooting Federation of France;
* Aged \>= 14 years;
* Informed consent signed by adult athlete or by holder of parental authority or guardian for minor athlete;
* Covered by social security system.

Exclusion Criteria

* Temporary or definitive contraindication to the practice of the affected sport activity;
* Undergoing anti-coagulated treatments;
* Cognitive disabilities conducting impossibility to participating to clinical trial, such as serious cognitive troubles, behaviors troubles, psychic troubles or upgraded curatorship needing;
* Under guardianship or judicial decision;
* Ongoing pregnancy.
Minimum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

François Genêt, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Service Médecine Physique et de Réadaptation, Hôpital Raymond Poincaré, APHP

Jean François Toussaint, MD, PhD

Role: STUDY_DIRECTOR

Centre d'Investigation en Médecine du Sport, Hôpital Hôtel Dieu, APHP

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service Médecine Physique et de Réadaptation, Hôpital Raymond Poincaré, APHP

Garches, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jean François Toussaint, MD, PhD

Role: CONTACT

+33 (0)1 42 34 82 10

François Genêt, MD, PhD

Role: CONTACT

+33 (0)1.47.10.70.68

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020-A02919-30

Identifier Type: REGISTRY

Identifier Source: secondary_id

APHP201139

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Screening of Athletes
NCT02056990 COMPLETED